Original ResearchReduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment
Under a Creative Commons license
open access
Key words
antineoplastic treatment
BNT162b2 COVID-19 vaccination
anti-RBD IgG antibody response
safety
cancer
Cited by (0)
- †
Equal contributions.
© 2021 Published by Elsevier Ltd on behalf of European Society for Medical Oncology.